Non-pharmacological Treatment of Insomnia in Nursing Homes.

Pilot Study on the Feasibility of Non-pharmacological Treatment of Insomnia in Nursing Homes.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01091987

Enrollment

Registered

2010-03-24

Start date

2010-04-30

Completion date

2011-06-30

Last updated

2011-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

Insomnia

Brief summary

The study wants to examine the feasibility of a non-pharmacological approach for insomnia in nursing homes provided by trained nurses/paramedics and physicians.

Interventions

BEHAVIORALNon-pharmacological approach of insomnia

education on sleep, sleep hygiene, stimulus control, cognitive techniques

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

55 Years to No maximum

Healthy volunteers

Inclusion criteria

* Male and female nursing home residents of age 55+ with insomnia, defined as difficulty in getting to sleep, difficulty in staying asleep, early wakening, or non-restorative sleep

Exclusion criteria

* insufficient cognitive ability for self-reflection * dementia * insomnia caused by a medical disorder (hyperthyroidism, congestive heart failure, peripheral arterial disease, GORD, COPD/asthma, angina pectoris, benign prostatic hyperplasia, arthritis, other * insomnia caused by medication * substance misuse * other sleep disorder: restless legs syndrome, periodic limb movement disorder, sleep apnoea, narcolepsy * psychiatric disorder: psychotic or bipolar disorder in anamnesis, major depression present or more than 2 episodes in anamnesis * short stay

Design outcomes

Primary

Measure	Time frame	Description
The proportion of eligible residents who accepted to participate in the non-pharmacological program and the proportion of eligible residents who completed the non-pharmacological program.	after 3 months	Evaluation takes place at the moment the program is ended according to the trained caregiver or maximally 3 months after the start of the program.

Secondary

Measure	Time frame	Description
Insomnia, as measured by the Groningen Sleep Quality Questionnaire	at baseline and after 3 months	—
quality of life	at baseline and after 3 months	measured by the Geriatric Behaviour Observation Scale
Use of sleep medication	at baseline and after 3 months	—

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026